Brain-gut microbiome interactions and functional bowel disorders

Gastroenterology

Volumn 146, Issue 6, 2014, Pages 1500-1512

  Mayer, Emeran A ^a   Savidge, Tor ^b,d   Shulman, Robert J ^b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CHILDREN S NUTRITION RESEARCH CENTER   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Dysbiosis; Irritable Bowel Syndrome; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; BILE ACID; NEUROTRANSMITTER; PREBIOTIC AGENT; PROBIOTIC AGENT; PROTEINASE;

ARTICLE; BRAIN; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; DIET; DYSBIOSIS; HUMAN; INTESTINE FLORA; INTESTINE FUNCTION; INTESTINE FUNCTION DISORDER; IRRITABLE COLON; METABOLITE; MOLECULE; NEUROTRANSMITTER RELEASE; ORGANISMAL INTERACTION; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

DYSBIOSIS; IRRITABLE BOWEL SYNDROME; PROBIOTICS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BACTERIA; BRAIN; DYSBIOSIS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MICROBIOTA; NEURAL PATHWAYS; PROBIOTICS; SIGNAL TRANSDUCTION;

EID: 84898777631     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2014.02.037     Document Type: Article

References (142)

1. E.A. Mayer Gut feelings: the emerging biology of gut-brain communication Nat Rev Neurosci 12 2011 453 466
2. S.H. Rhee, C. Pothoulakis, and E.A. Mayer Principles and clinical implications of the brain-gut-enteric microbiota axis Nat Rev Gastroenterol Hepatol 6 2009 306 314
3. T.H. Frazier, J.K. DiBaise, and C.J. McClain Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury JPEN J Parenter Enteral Nutr 35 2011 14S 20S
4. J.L. Round, and S.K. Mazmanian The gut microbiota shapes intestinal immune responses during health and disease Nat Rev Immunol 9 2009 313 323
5. P. Forsythe, and W.A. Kunze Voices from within: gut microbes and the CNS Cell Mol Life Sci 70 2013 55 69
6. N. Sudo, Y. Chida, and Y. Aiba et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice J Physiol 558 2004 263 275
7. F.A. Amaral, D. Sachs, and V.V. Costa et al. Commensal microbiota is fundamental for the development of inflammatory pain Proc Natl Acad Sci U S A 105 2008 2193 2197
8. J.F. Cryan, and T.G. Dinan Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour Nat Rev Neurosci 13 2012 701 712
9. P. Bercik, S.M. Collins, and E.F. Verdu Microbes and the gut-brain axis Neurogastroenterol Motil 24 2012 405 413
10. M. Camilleri, K. Lasch, and W. Zhou Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome Am J Physiol Gastrointest Liver Physiol 303 2012 G775 G785
11. J. Matricon, M. Meleine, and A. Gelot et al. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome Aliment Pharmacol Ther 36 2012 1009 1031
12. M. Simren, G. Barbara, and H.J. Flint et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report Gut 62 2013 159 176
13. Y. Ringel, and N. Maharshak Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome Am J Physiol Gastrointest Liver Physiol 305 2013 G529 G541
14. P.A. Hughes, H. Zola, and I.A. Penttila et al. Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? Am J Gastroenterol 108 2013 1066 1074
15. E.E. Valdez-Morales, J. Overington, and R. Guerrero-Alba et al. Sensitization of peripheral sensory nerves by mediators from colonic biopsies of diarrhea-predominant irritable bowel syndrome patients: a role for PAR2 Am J Gastroenterol 108 2013 1634 1643
16. P.D. Cani, A. Everard, and T. Duparc Gut microbiota, enteroendocrine functions and metabolism Curr Opin Pharmacol 13 2013 935 940
17. R. Diaz Heijtz, S. Wang, and F. Anuar et al. Normal gut microbiota modulates brain development and behavior Proc Natl Acad Sci U S A 108 2011 3047 3052
18. K.M. Neufeld, N. Kang, and J. Bienenstock et al. Reduced anxiety-like behavior and central neurochemical change in germ-free mice Neurogastroenterol Motil 23 2011 255 264 e119
19. M.G. Gareau, E. Wine, and D.M. Rodrigues et al. Bacterial infection causes stress-induced memory dysfunction in mice Gut 60 2011 307 317
20. K. Tillisch, J. Labus, and L. Kilpatrick et al. Consumption of fermented milk product with probiotic modulates brain activity Gastroenterology 144 2013 1394 1401 1401 e1-e4
21. F. Backhed, C.M. Fraser, and Y. Ringel et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications Cell Host Microbe 12 2012 611 622
22. E. Le Chatelier, T. Nielsen, and J. Qin et al. Richness of human gut microbiome correlates with metabolic markers Nature 500 2013 541 546
23. B.A. Methe, K.E. Nelson, and M. Pop et al. A framework for human microbiome research Nature 486 2012 215 221
24. K. Li, M. Bihan, and S. Yooseph et al. Analyses of the microbial diversity across the human microbiome PLoS One 7 2012 e32118
25. Z.K. Wang, and Y.S. Yang Upper gastrointestinal microbiota and digestive diseases World J Gastroenterol 19 2013 1541 1550
26. A.P. Kerckhoffs, K. Ben-Amor, and M. Samsom et al. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome J Med Microbiol 60 2011 236 245
27. M.F. Pimentel, E.J. Giamarellos-Bourboulis, and E. Pyleris et al. The first large scale deep sequencing of the duodenal microbiome in irritable bowel syndrome reveals striking differences compared to healthy controls Gastroenterology 144 2013 S59
28. M.T. Bailey, and C.L. Coe Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys Dev Psychobiol 35 1999 146 155
29. M.T. Bailey, J.W. Karaszewski, and G.R. Lubach et al. In vivo adaptation of attenuated Salmonella typhimurium results in increased growth upon exposure to norepinephrine Physiol Behav 67 1999 359 364
30. M.T. Bailey, G.R. Lubach, and C.L. Coe Prenatal stress alters bacterial colonization of the gut in infant monkeys J Pediatr Gastroenterol Nutr 38 2004 414 421
31. C. De Filippo, D. Cavalieri, and M. Di Paola et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa Proc Natl Acad Sci U S A 107 2010 14691 14696
32. G.D. Wu, J. Chen, and C. Hoffmann et al. Linking long-term dietary patterns with gut microbial enterotypes Science 334 2011 105 108
33. L.A. David, C.F. Maurice, and R.N. Carmody et al. Diet rapidly and reproducibly alters the human gut microbiome Nature 505 2014 559 563
34. I.B. Jeffery, and P.W. O'Toole Diet-microbiota interactions and their implications for healthy living Nutrients 5 2013 234 252
35. K.A. Gwee Irritable bowel syndrome in developing countries-a disorder of civilization or colonization? Neurogastroenterol Motil 17 2005 317 324
36. E.A. Williams, X. Nai, and B.M. Corfe Dietary intakes in people with irritable bowel syndrome BMC Gastroenterol 11 2011 9
37. L. Bohn, S. Storsrud, and M. Simren Nutrient intake in patients with irritable bowel syndrome compared with the general population Neurogastroenterol Motil 25 2013 23 30.e1
38. M. El-Salhy, H. Ostgaard, and D. Gundersen et al. The role of diet in the pathogenesis and management of irritable bowel syndrome (review) Int J Mol Med 29 2012 723 731
39. M. Jarrett, M.M. Heitkemper, and E.F. Bond et al. Comparison of diet composition in women with and without functional bowel disorder Gastroenterol Nurs 16 1994 253 258
40. A. Durban, J.J. Abellan, and N. Jimenez-Hernandez et al. Assessing gut microbial diversity from feces and rectal mucosa Microb Ecol 61 2011 123 133
41. I.M. Carroll, T. Ringel-Kulka, and T.O. Keku et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome Am J Physiol Gastrointest Liver Physiol 301 2011 G799 G807
42. A. Durban, J.J. Abellan, and N. Jimenez-Hernandez et al. Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome Environ Microbiol Rep 4 2012 242 247
43. I.B. Jeffery, P.W. O'Toole, and L. Ohman et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota Gut 61 2012 997 1006
44. N.P. McNulty, T. Yatsunenko, and A. Hsiao et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins Sci Transl Med 3 2011 106ra106
45. P.C. Kashyap, A. Marcobal, and L.K. Ursell et al. Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiota Proc Natl Acad Sci U S A 110 2013 17059 17064
46. J. Kopečný, and J. Šimůnek Cellulolytic bacteria in the human gut and irritable bowel syndrome Acta Vet Brno 71 2002 421 427
47. G. Le Gall, S.O. Noor, and K. Ridgway et al. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome J Proteome Res 10 2011 4208 4218
48. P.B. Mortensen, J.R. Andersen, and S. Arffmann et al. Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran Scand J Gastroenterol 22 1987 185 192
49. C. Tana, Y. Umesaki, and A. Imaoka et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome Neurogastroenterol Motil 22 2010 512 515
50. W.R. Treem, N. Ahsan, and G. Kastoff et al. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation J Pediatr Gastroenterol Nutr 23 1996 280 286
51. K. Kajander, E. Myllyluoma, and S. Kyronpalo et al. Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome World J Gastroenterol 15 2009 6068 6074
52. I. Ahmed, R. Greenwood, and L. Costello Bde et al. An investigation of fecal volatile organic metabolites in irritable bowel syndrome PLoS One 8 2013 e58204
53. E.P. Halmos, V.A. Power, and S.J. Shepherd et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome Gastroenterology 146 2014 67 75
54. J.R. Biesiekierski, S.L. Peters, and E.D. Newnham et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates Gastroenterology 145 2013 320-328 e1-e3
55. K. Whelan Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews Curr Opin Clin Nutr Metab Care 14 2011 581 587
56. M. Olesen, and E. Gudmand-Hoyer Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome Am J Clin Nutr 72 2000 1570 1575
57. D.B. Silk, A. Davis, and J. Vulevic et al. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome Aliment Pharmacol Ther 29 2009 508 518
58. M.E. Sanders, F. Guarner, and R. Guerrant et al. An update on the use and investigation of probiotics in health and disease Gut 62 2013 787 796
59. M. Ortiz-Lucas, A. Tobias, and P. Saz et al. Effect of probiotic species on irritable bowel syndrome symptoms: a bring up to date meta-analysis Rev Esp Enferm Dig 105 2013 19 36
60. A. Horvath, P. Dziechciarz, and H. Szajewska Meta-analysis: Lactobacillus rhamnosus GG for abdominal pain-related functional gastrointestinal disorders in childhood Aliment Pharmacol Ther 33 2011 1302 1310
61. S.B. Menees, M. Maneerattannaporn, and H.M. Kim et al. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis Am J Gastroenterol 107 2012 28 35 quiz 36
62. P. Enck, F. Junne, and S. Klosterhalfen et al. Therapy options in irritable bowel syndrome Eur J Gastroenterol Hepatol 22 2010 1402 1411
63. B.S. Collins, and H.C. Lin Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain J Pediatr Gastroenterol Nutr 52 2011 382 386
64. A.H. Sachdev, and M. Pimentel Antibiotics for irritable bowel syndrome: rationale and current evidence Curr Gastroenterol Rep 14 2012 439 445
65. H.L. DuPont, Z.D. Jiang, and P.C. Okhuysen et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea Ann Intern Med 142 2005 805 812
66. J. Cheng, Y.M. Shah, and F.J. Gonzalez Pregnane X receptor as a target for treatment of inflammatory bowel disorders Trends Pharmacol Sci 33 2012 323 330
67. D. Xu, J. Gao, and M. Gillilland 3rd et al. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats Gastroenterology 146 2014 484 496.e4
68. R.C. Spiller Postinfectious irritable bowel syndrome Gastroenterology 124 2003 1662 1671
69. M.A. Mendall, and D. Kumar Antibiotic use, childhood affluence and irritable bowel syndrome (IBS) Eur J Gastroenterol Hepatol 10 1998 59 62
70. P.R. Maxwell, E. Rink, and D. Kumar et al. Antibiotics increase functional abdominal symptoms Am J Gastroenterol 97 2002 104 108
71. A.A. Villarreal, F.J. Aberger, and R. Benrud et al. Use of broad-spectrum antibiotics and the development of irritable bowel syndrome WMJ 111 2012 17 20
72. G. Barbara, V. Stanghellini, and C. Berti-Ceroni et al. Role of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infection Aliment Pharmacol Ther 14 2000 1127 1131
73. K. Marild, W. Ye, and B. Lebwohl et al. Antibiotic exposure and the development of coeliac disease: a nationwide case-control study BMC Gastroenterol 13 2013 109
74. L. Trasande, J. Blustein, and M. Liu et al. Infant antibiotic exposures and early-life body mass Int J Obes (Lond) 37 2013 16 23
75. E.A. Mayer The neurobiology of stress and gastrointestinal disease Gut 47 2000 861 869
76. I.D. Van Felius, L.M. Akkermans, and K. Bosscha et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis Neurogastroenterol Motil 15 2003 267 276
77. A. Lembo, and M. Camilleri Chronic constipation N Engl J Med 349 2003 1360 1368
78. W.Y. Chey, H.O. Jin, and M.H. Lee et al. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea Am J Gastroenterol 96 2001 1499 1506
79. S. Macfarlane, and J.F. Dillon Microbial biofilms in the human gastrointestinal tract J Appl Microbiol 102 2007 1187 1196
80. C. Alonso, M. Guilarte, and M. Vicario et al. Maladaptive intestinal epithelial responses to life stress may predispose healthy women to gut mucosal inflammation Gastroenterology 135 2008 163 172.e1
81. J. Groot, P. Bijlsma, and A. Van Kalkeren et al. Stress-induced decrease of the intestinal barrier function. The role of muscarinic receptor activation Ann N Y Acad Sci 915 2000 237 246
82. C. Jacob, P.C. Yang, and D. Darmoul et al. Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins J Biol Chem 280 2005 31936 31948
83. A.J. Kiliaan, P.R. Saunders, and P.B. Bijlsma et al. Stress stimulates transepithelial macromolecular uptake in rat jejunum Am J Physiol 275 1998 G1037 G1044
84. J.D. Soderholm, D.A. Yates, and M.G. Gareau et al. Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress Am J Physiol Gastrointest Liver Physiol 283 2002 G1257 G1263
85. D.A. Yates, J. Santos, and J.D. Söderholm et al. Adaptation of stress-induced mucosal pathophysiology in rat colon involves opioid pathways Am J Physiol Gastrointest Liver Physiol 281 2001 G124 G128
86. A.V. Keita, and J.D. Soderholm The intestinal barrier and its regulation by neuroimmune factors Neurogastroenterol Motil 22 2010 718 733
87. M.T. Bailey, S.E. Dowd, and N.M. Parry et al. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium Infect Immun 78 2010 1509 1519
88. G.W. Tannock, and D.C. Savage Influences of dietary and environmental stress on microbial populations in the murine gastrointestinal tract Infect Immun 9 1974 591 598
89. M.T. Bailey, S.E. Dowd, and J.D. Galley et al. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation Brain Behav Immun 25 2011 397 407
90. M. Lyte, and P.P.E.E. Freestone Microbial endocrinology: interkingdom signaling in health and disease 2010 Springer Publishers New York
91. J. Santos, E. Saperas, and C. Nogueiras et al. Release of mast cell mediators into the jejunum by cold pain stress in humans Gastroenterology 114 1998 640 648
92. R.L. Stephens, and Y. Tache Intracisternal injection of a TRH analogue stimulates gastric luminal serotonin release in rats Am J Physiol 256 1989 G377 G383
93. H. Yang, R.L. Stephens, and Y. Tache TRH analogue microinjected into specific medullary nuclei stimulates gastric serotonin secretion in rats Am J Physiol 262 1992 G216 G222
94. J. Alverdy, C. Holbrook, and F. Rocha et al. Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: evidence for in vivo virulence expression in Pseudomonas aeruginosa Ann Surg 232 2000 480 489
95. D.T. Hughes, and V. Sperandio Inter-kingdom signalling: communication between bacteria and their hosts Nat Rev Microbiol 6 2008 111 120
96. Y. Asano, T. Hiramoto, and R. Nishino et al. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice Am J Physiol Gastrointest Liver Physiol 303 2012 G1288 G1295
97. M. Lyte Microbial endocrinology and infectious disease in the 21st century Trends Microbiol 12 2004 14 20
98. T.A. Cogan, A.O. Thomas, and L.E. Rees et al. Norepinephrine increases the pathogenic potential of Campylobacter jejuni Gut 56 2007 1060 1065
99. E.W. Fish, D. Shahrokh, and R. Bagot et al. Epigenetic programming of stress responses through variations in maternal care Ann N Y Acad Sci 1036 2004 167 180
100. M.J. Meaney Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations Ann Rev Neurosci 24 2001 1161 1192
101. J.H. Cummings, E.W. Pomare, and W.J. Branch et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood Gut 28 1987 1221 1227
102. P.M. Smith, M.R. Howitt, and N. Panikov et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis Science 341 2013 569 573
103. M.A. Vinolo, G.J. Ferguson, and S. Kulkarni et al. SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor PLoS One 6 2011 e21205
104. B.T. Layden, A.R. Angueira, and M. Brodsky et al. Short chain fatty acids and their receptors: new metabolic targets Transl Res 161 2013 131 140
105. M. Nepelska, A. Cultrone, and F. Beguet-Crespel et al. Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cells PLoS One 7 2012 e52869
106. V. Ganapathy, M. Thangaraju, and P.D. Prasad et al. Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host Curr Opin Pharmacol 13 2013 869 874
107. L.B. Bindels, E.M. Dewulf, and N.M. Delzenne GPR43/FFA2: physiopathological relevance and therapeutic prospects Trends Pharmacol Sci 34 2013 226 232
108. G.A. Cresci, M. Thangaraju, and J.D. Mellinger et al. Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8 J Gastrointest Surg 14 2010 449 461
109. S. Karaki, R. Mitsui, and H. Hayashi et al. Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine Cell Tissue Res 324 2006 353 360
110. M.K. Nohr, M.H. Pedersen, and A. Gille et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes Endocrinology 154 2013 3552 3564
111. S.A. Vanhoutvin, F.J. Troost, and T.O. Kilkens et al. The effects of butyrate enemas on visceral perception in healthy volunteers Neurogastroenterol Motil 21 2009 952-e76
112. T. Banasiewicz, L. Krokowicz, and Z. Stojcev et al. Microencapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome Colorectal Dis 15 2013 204 209
113. M. Camilleri Peripheral mechanisms in irritable bowel syndrome N Engl J Med 367 2012 1626 1635
114. H. Abrahamsson, A.M. Ostlund-Lindqvist, and R. Nilsson et al. Altered bile acid metabolism in patients with constipation-predominant irritable bowel syndrome and functional constipation Scand J Gastroenterol 43 2008 1483 1488
115. K. Gecse, R. Roka, and L. Ferrier et al. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity Gut 57 2008 591 599
116. N. Cenac, C.N. Andrews, and M. Holzhausen et al. Role for protease activity in visceral pain in irritable bowel syndrome J Clin Invest 117 2007 636 647
117. A. Annahazi, L. Ferrier, and V. Bezirard et al. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS Am J Gastroenterol 108 2013 1322 1331
118. T. Saito, and N.W. Bunnett Protease-activated receptors: regulation of neuronal function Neuromolecular Med 7 2005 79 99
119. I.M. Carroll, T. Ringel-Kulka, and L. Ferrier et al. Fecal protease activity is associated with compositional alterations in the intestinal microbiota PLoS One 8 2013 e78017
120. N. Steck, K. Mueller, and M. Schemann et al. Bacterial proteases in IBD and IBS Gut 61 2012 1610 1618
121. D. Tooth, K. Garsed, and G. Singh et al. Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit Gut 2013 Epub ahead of print
122. T. Midtvedt, E. Zabarovsky, and E. Norin et al. Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform PLoS One 8 2013 e66074
123. G. Barbara, B. Wang, and V. Stanghellini et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome Gastroenterology 132 2007 26 37
124. G.T. Macfarlane, C. Allison, and S.A. Gibson et al. Contribution of the microflora to proteolysis in the human large intestine J Appl Bacteriol 64 1988 37 46
125. R. Roka, A. Rosztoczy, and M. Leveque et al. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome Clin Gastroenterol Hepatol 5 2007 550 555
126. A. Balsari, A. Ceccarelli, and F. Dubini et al. The fecal microbial population in the irritable bowel syndrome Microbiologica 5 1982 185 194
127. J.M. Si, Y.C. Yu, and Y.J. Fan et al. Intestinal microecology and quality of life in irritable bowel syndrome patients World J Gastroenterol 10 2004 1802 1805
128. J. Matto, L. Maunuksela, and K. Kajander et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects FEMS Immunol Med Microbiol 43 2005 213 222
129. I.M. Carroll, Y.H. Chang, and J. Park et al. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome Gut Pathog 2 2010 19
130. E. Malinen, T. Rinttila, and K. Kajander et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR Am J Gastroenterol 100 2005 373 382
131. A.P. Kerckhoffs, M. Samsom, and M.E. van der Rest et al. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients World J Gastroenterol 15 2009 2887 2892
132. M. Rajilic-Stojanovic, E. Biagi, and H.G. Heilig et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome Gastroenterology 141 2011 1792 1801
133. D.M. Saulnier, K. Riehle, and T.A. Mistretta et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome Gastroenterology 141 2011 1782 1791
134. L. Krogius-Kurikka, A. Lyra, and E. Malinen et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers BMC Gastroenterol 9 2009 95
135. P. Moayyedi, A.C. Ford, and N.J. Talley et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review Gut 59 2010 325 332
136. N. Hoveyda, C. Heneghan, and K.R. Mahtani et al. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome BMC Gastroenterol 9 2009 15
137. L.V. McFarland, and S. Dublin Meta-analysis of probiotics for the treatment of irritable bowel syndrome World J Gastroenterol 14 2008 2650 2661
138. T. Kamiya, L. Wang, and P. Forsythe et al. Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats Gut 55 2006 191 196
139. C. Rousseaux, X. Thuru, and A. Gelot et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors Nat Med 13 2007 35 37
140. E.F. Verdu, P. Bercik, and M. Verma-Gandhu et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice Gut 55 2006 182 190
141. P. Bercik, E.F. Verdu, and J.A. Foster et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice Gastroenterology 139 2010 2102 2112.e1
142. J.A. Bravo, P. Forsythe, and M.V. Chew et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve Proc Natl Acad Sci U S A 108 2011 16050 16055